Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Prostate Cancer
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Prostate Cancer
    Prostate Cancer Patients Disease Free After 5 Years Likely to Be Disease Free After 10 Years - (DGNews)
    Selenium May Worsen Prostate Cancer in Men With SOD2 Gene Variant - (DGNews)
    TopAbstracts in Prostate Cancer 06/24/2009 - (DGNews)
    Prostate Cancer Test Improves Prediction of Disease Course - (DGNews)
    Duration of androgen suppression in the treatment of prostate cancer - (N Engl J Med)

    News archive

     Recent webcasts/CME - Prostate Cancer
    • Exploring the Link Between Hypogonadism and Metabolic Comorbidities
    • Diagnosing Hypogonadism: Recommendations for Testing and Treating to Improve Outcomes
    • Remplacement de la testostérone : surveillance d'un point de vue pratique
    • Finasteride and Prostate Cancer Prevention: The Latest Chapter
      Emerging Research May Improve Prostate Cancer Treatment

      Webcasts/CME archive

       Recent cases - Prostate Cancer
        Non-Prostatic Pathology on Prostate Needle-Biopsy - Colorectal Carcinoid: A Case Report
        A 70-Year-Old Male Having Advanced Prostate Cancer Presenting with Hypercalcemia and Diffuse Osteoblastic Bone Metastases: A Case Report
        A Dramatic, Objective Antiandrogen Withdrawal Response: Case Report and Review of the Literature
        Anejaculation as an Atypical Presentation of Prostate Cancer: A Case Report
        FDG PET-CT Demonstration of Metastatic Neuroendocrine Tumor of Prostate

        Cases archive
          




        my personal edition > prostate cancer > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        More Support For Link Between Calcium And Prostate Cancer Risk

        American Journal of Clinical Nutrition

        10/01/2001
        By Elda Hauschildt


        Data from the United States Physicians? Health Study offers more support for the association between high intake of calcium from dairy products and a greater risk of prostate cancer.

        During 11 years of follow-up, North American researchers documented 1,012 incident cases of prostate cancer among 20,885 doctors in the study.

        "Compared with men consuming 150 milligrams or less of calcium per day from dairy products, men consuming more than 600 mg/d had a 32 percent higher risk of prostate cancer," they report.

        Investigators say their results support and extend previous observations that high intakes of dairy products, and of calcium from dairy foods specifically, are associated with an increased risk of prostate cancer.

        "These findings may serve to interject a note of caution into the current enthusiastic promotion of a higher intake of calcium in the US," they add.

        They explain that a high calcium intake, mainly from dairy products, could increase prostate cancer risk by lowering concentrations of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3]. They add that 1,25(OH)2D3 is a hormone believed to help protect against prostate cancer.

        Participants in the overall Physicians' Health Study completed questionnaires at start-up in 1982. They reported annually through 1995 in a randomised, blinded, placebo-controlled trial that looked at their aspirin and beta-carotene use.

        In this study, researchers from Harvard University, Brigham and Women?s Hospital and the Veterans Administration Boston Health Care System, all in Boston, Massachusetts, and Northwestern University in Chicago, Illinois used data from participants who returned dietary questionnaires, provided body mass index statistics and did not have a cancer diagnosis at baseline.

        Their follow-up was more than 99 percent complete.

        Investigators estimated dairy calcium intake using consumption of five major dairy products. They used logistic regression to estimate relative risk.

        "At baseline, men who consumed more than 600 mg Ca/d from skim milk had lower plasma 1,25(OH)2D3 concentrations than did those consuming 150 mg Ca/d or less," they say.

        "Compared with men consuming 0.5 daily servings of dairy products or less, those consuming more than 2.5 servings had a multivariate relative risk of prostate cancer of 1.34, after adjustment for baseline age, [body mass index], smoking, exercise and randomised treatment assignment in the original placebo-controlled trial."

        Researchers note that the positive associations for dairy products and dairy calcium especially remained after they adjusted for total food scores.

        "Thus, our inability to control for total energy probably introduced little or no bias, and random classification of the main exposure as a result of incomplete dairy calcium assessment would lead to an underestimate of any true associations," they conclude.
        American Journal of Clinical Nutrition, 2001; 74: 549-554

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send